ENTINOSTAT for Myelodysplastic syndrome: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where ENTINOSTAT was used for Myelodysplastic syndrome.
Most Reported Side Effects for ENTINOSTAT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Infection | 12 | 9.8% | 10 | 0 |
| Anaemia | 11 | 8.9% | 3 | 5 |
| Death | 10 | 8.1% | 10 | 5 |
| Pyrexia | 9 | 7.3% | 4 | 8 |
| Abdominal pain | 8 | 6.5% | 0 | 7 |
| Disease progression | 8 | 6.5% | 8 | 0 |
| Sepsis | 8 | 6.5% | 6 | 5 |
| Thrombocytopenia | 8 | 6.5% | 3 | 2 |
| Fatigue | 7 | 5.7% | 0 | 3 |
| Diarrhoea | 6 | 4.9% | 1 | 4 |
| Febrile neutropenia | 6 | 4.9% | 2 | 3 |
| Hypotension | 6 | 4.9% | 1 | 6 |
| Asthenia | 5 | 4.1% | 0 | 3 |
| Confusional state | 5 | 4.1% | 3 | 4 |
| Dehydration | 5 | 4.1% | 1 | 4 |
Other Indications for ENTINOSTAT
Renal cell carcinoma (24)
Acute myeloid leukaemia (21)
Breast cancer (16)
Product used for unknown indication (8)
Adenocarcinoma pancreas (5)
Other Drugs Used for Myelodysplastic syndrome
LENALIDOMIDE (14,132)
AZACITIDINE (5,741)
VENETOCLAX (2,508)
DEFERASIROX (1,445)
DARBEPOETIN ALFA (1,164)
RUXOLITINIB (886)
REVLIMID (835)
CEDAZURIDINE\DECITABINE (770)
LUSPATERCEPT-AAMT (609)
DECITABINE (429)